1
|
Kansara M and Thomas DM: Molecular
pathogenesis of osteosarcoma. DNA Cell Biol. 26:1–18. 2007.
View Article : Google Scholar
|
2
|
Broadhead ML, Clark JC, Myers DE, Dass CR
and Choong PF: The molecular pathogenesis of osteosarcoma: a
review. Sarcoma. 2011:9592482011. View Article : Google Scholar : PubMed/NCBI
|
3
|
Khanna C, Wan X, Bose S, et al: The
membrane-cytoskeleton linker ezrin is necessary for osteosarcoma
metastasis. Nat Med. 10:182–186. 2004. View
Article : Google Scholar : PubMed/NCBI
|
4
|
Zhang P, Yang Y, Zweidler-McKay PA and
Hughes DP: Critical role of notch signaling in osteosarcoma
invasion and metastasis. Clin Cancer Res. 14:2962–2969. 2008.
View Article : Google Scholar : PubMed/NCBI
|
5
|
Su Y, Wagner ER, Luo Q, et al:
Insulin-like growth factor binding protein 5 suppresses tumor
growth and metastasis of human osteosarcoma. Oncogene.
30:3907–3917. 2011. View Article : Google Scholar : PubMed/NCBI
|
6
|
Zhang P, Yang Y, Zweidler-McKay PA and
Hughes DP: Critical role of notch signaling in osteosarcoma
invasion and metastasis. Clin Cancer Res. 14:2962–2969. 2008.
View Article : Google Scholar : PubMed/NCBI
|
7
|
Ando T, Ichikawa J, Okamoto A, Tasaka K,
Nakao A and Hamada Y: Gemcitabine inhibits viability, growth, and
metastasis of osteosarcoma cell lines. J Orthop Res. 23:964–969.
2005. View Article : Google Scholar : PubMed/NCBI
|
8
|
Kim SM, Lee H, Park YS, Lee Y and Seo SW:
ERK5 regulates invasiveness of osteosarcoma by inducing MMP-9. J
Orthop Res. 30:1040–1044. 2012. View Article : Google Scholar : PubMed/NCBI
|
9
|
Gvozdenovic A, Arlt MJ, Campanile C, et
al: CD44 enhances tumor formation and lung metastasis in
experimental osteosarcoma and is an additional predictor for poor
patient outcome. J Bone Miner Res. 28:838–847. 2013. View Article : Google Scholar : PubMed/NCBI
|
10
|
Liu X, Choy E, Hornicek FJ, et al: ROCK1
as a potential therapeutic target in osteosarcoma. J Orthop Res.
29:1259–1266. 2011. View Article : Google Scholar : PubMed/NCBI
|
11
|
Wang SW, Wu HH, Liu SC, et al: CCL5 and
CCR5 interaction promotes cell motility in human osteosarcoma. PLoS
One. 7:e351012012. View Article : Google Scholar : PubMed/NCBI
|
12
|
Kang H, Wilson CS, Harvey RC, et al: Gene
expression profiles predictive of outcome and age in infant acute
lymphoblastic leukemia: a Children’s Oncology Group study. Blood.
119:1872–1881. 2012.PubMed/NCBI
|
13
|
Kadota M, Sato M, Duncan B, et al:
Identification of novel gene amplifications in breast cancer and
coexistence of gene amplification with an activating mutation of
PIK3CA. Cancer Res. 69:7357–7365. 2009. View Article : Google Scholar : PubMed/NCBI
|
14
|
Adamowicz M, Radlwimmer B, Rieker RJ, et
al: Frequent amplifications and abundant expression of TRIO, NKD2,
and IRX2 in soft tissue sarcomas. Genes Chromosomes Cancer.
45:829–838. 2006. View Article : Google Scholar : PubMed/NCBI
|
15
|
Rauch TA, Wang Z, Wu X, Kernstine KH,
Riggs AD and Pfeifer GP: DNA methylation biomarkers for lung
cancer. Tumour Biol. 33:287–296. 2012. View Article : Google Scholar : PubMed/NCBI
|
16
|
Stamenkovic I: Matrix metalloproteinases
in tumor invasion and metastasis. Semin Cancer Biol. 10:415–433.
2000. View Article : Google Scholar : PubMed/NCBI
|
17
|
Xue G, Restuccia DF, Lan Q, et al:
Akt/PKB-mediated phosphorylation of Twist1 promotes tumor
metastasis via mediating cross-talk between PI3K/Akt and TGF-β
signaling axes. Cancer Discov. 2:248–259. 2012.PubMed/NCBI
|
18
|
Teranishi F, Takahashi N, Gao N, et al:
Phosphoinositide 3-kinase inhibitor (wortmannin) inhibits
pancreatic cancer cell motility and migration induced by hyaluronan
in vitro and peritoneal metastasis in vivo. Cancer Sci.
100:770–777. 2009. View Article : Google Scholar : PubMed/NCBI
|
19
|
Fang Y, Xue JL, Shen Q, Chen J and Tian L:
MicroRNA-7 inhibits tumor growth and metastasis by targeting the
phosphoinositide 3-kinase/Akt pathway in hepatocellular carcinoma.
Hepatology. 55:1852–1862. 2012. View Article : Google Scholar : PubMed/NCBI
|
20
|
Lu Y and Wahl LM: Production of matrix
metalloproteinase-9 by activated human monocytes involves a
phosphatidylinositol-3 kinase/Akt/IKKalpha/NF-kappaB pathway. J
Leukoc Biol. 78:259–265. 2005. View Article : Google Scholar : PubMed/NCBI
|
21
|
Gustin JA, Ozes ON, Akca H, et al: Cell
type-specific expression of the IkappaB kinases determines the
significance of phosphatidylinositol 3-kinase/Akt signaling to
NF-kappa B activation. J Biol Chem. 279:1615–1620. 2004. View Article : Google Scholar : PubMed/NCBI
|